Aurora Cannabis (NASDAQ: ACB) has long been an underperforming marijuana stock. There's definitely risk involved here, but investors have seen just how quickly the stock can rise on some bullishness; shares of Aurora skyrocketed to highs of nearly $19 in February amid the meme hype. Should contrarian investors consider picking up the stock before the company announces its year-end results in September?
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting